A61P 13 - Drugs for disorders of the urinary system

Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
12/2001
12/06/2001	CA2410734A1 Dnas encoding mammalian histamine receptor of the h4 subtype
12/06/2001	CA2410660A1 Cyclohexylamine derivatives as subtype selective nmda receptor antagonists
12/06/2001	CA2410655A1 Dihydropyridine compounds for the inhibition of calcium-influx
12/06/2001	CA2410453A1 Neuroprotective peptides
12/06/2001	CA2410084A1 Transporters and ion channels
12/06/2001	CA2409311A1 Regulators of apoptosis
12/06/2001	CA2409006A1 Biciclic cyclohexylamines and their use as nmda receptor antogonists
12/06/2001	CA2406979A1 Indole derivatives with vascular damaging activity
12/05/2001	EP1160254A1 Human vanilloid receptor-like proteins
12/05/2001	EP1160248A1 N-(Isoxazol-5-yl)-sulfonamide derivatives and their use as endothelin antagonists
12/05/2001	EP1159975A2 Anti-angiogenic compositions and methods of use
12/05/2001	EP1159974A1 Anti-angiogenic compositions and methods of use
12/05/2001	EP1159420A1 Human pancreas and pancreatic cancer associated gene sequences and polypeptides
12/05/2001	EP1159291A1 C-terminal modified (n-substituted)-2-indolylcarbonyldipeptides as inhibitors of the ice/ced-3 family of cysteine proteases
12/05/2001	EP1159286A1 Tumor necrosis factor receptors 6 alpha and 6 beta
12/05/2001	EP1159284A1 33 human secreted proteins
12/05/2001	EP1159265A1 C-16 unsaturated fp-selective prostaglandins analogs
12/05/2001	EP1158996A1 Novel amide derivatives as growth hormone secretagogues
12/05/2001	EP1158984A1 Inhibitors of prenyl-protein transferase
12/05/2001	EP1158983A1 Inhibitors of prenyl-protein transferase
12/05/2001	EP1158982A2 Inhibitors of prenyl-protein transferase
12/05/2001	EP1158975A1 Use of isoflavones and/or african plum extracts for preparing a composition designed to inhibit 5$g(a)-reductase activity, in pharmacology particularly in dermatology, in cosmetics and as food additive
12/05/2001	EP1158958A1 Improved powdery pharmaceutical compositions for inhalation
12/05/2001	EP1146035A9 Crystal polymorphism of aminoethylphenoxyacetic acid derivative
12/05/2001	EP1063983B1 Transdermal therapeutic system (tts) containing oxybutynin
12/05/2001	EP1017377B1 Use of 6, 7-substituted 2-aminotetralines for the treatment of cytokine mediated inflammatory conditions
12/05/2001	EP0971880B1 Solid compositions suitable for oral administration comprising non hygroscopic salts of l-carnitine and alkanoyl-l-carnitine with 2-aminoethanesulfonic acid
12/05/2001	EP0937036B1 Substituted 4-biphenyl-4-hydroxybutyric acid derivatives as matrix metalloprotease inhibitors
12/05/2001	EP0828724B1 Diaryl-5-oxygenated-2-(5h)-furanones as cox-2 inhibitors
12/05/2001	EP0814800B1 Water-based topical cream containing nitroglycerin; method of preparation and use thereof
12/05/2001	CN1325408A Compounds with growth hormone releasing propenties
12/05/2001	CN1325390A 2-ureido-thiazole derivatives, process for their preparation, and their use as antitumor agents
12/05/2001	CN1325389A 2-amino-thiazole derivatives, process for their preparation, and their use as antitumor agents
12/05/2001	CN1325384A Anthranilic acid amides and the use thereof as medicaments
12/05/2001	CN1324639A Medicine for treating urinary tract calculus
12/05/2001	CN1324612A Medicine for delaying chronic kidney hypofunction
12/05/2001	CN1075816C Methods for in vivo reduction of nitric oxide levels and compositions sueful therefor
12/05/2001	CN1075724C Suppository for curing prostatosis
12/04/2001	US6326367 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents
12/04/2001	US6326181 Cell volume-regulated human kinase h-sgk
12/04/2001	CA2218452C Novel ligands of the neuropeptide receptor hfgan72
11/2001
11/30/2001	CA2348847A1 New isoxazole-sulfonamide endothelin antagonists
11/29/2001	WO2001090371A1 Mutated eukariotic translation initiation factor 2 alpha kinase 3, eif2ak3, in patients with neonatal insulin-dependent diabetes and multiple epiphyseal dysplasia (wolcott-rallison syndrome)
11/29/2001	WO2001090359A2 G-protein coupled receptors
11/29/2001	WO2001090334A2 Drug metabolizing enzymes
11/29/2001	WO2001090156A2 Card domain containing polypeptides, encoding nucleic acids, and methods of use
11/29/2001	WO2001090148A2 Neurotransmitter transporters
11/29/2001	WO2001090106A2 Tryasolyl tropane derivatives as ccr5 modulators
11/29/2001	WO2001090104A2 -(pyrrolidin-1-ylmethyl)-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as modulators of protein kinases
11/29/2001	WO2001090103A2 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as protein kinase modulators
11/29/2001	WO2001090086A1 A polymorph of 5-(4-aminosulfonyl-3-fluorophenyl)-4-cyclohexyl-2-methyloxazole
11/29/2001	WO2001090083A1 1,4-diazepan-2,5-dione derivatives and their use as nk-1 receptor antagonists
11/29/2001	WO2001090082A1 Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
11/29/2001	WO2001090081A1 Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
11/29/2001	WO2001090076A1 Fluoroalkoxy-substituted benzamide dichloropyridinyl n-oxide pde4 inhibitor
11/29/2001	WO2001090070A2 Caspase inhibitors and uses thereof
11/29/2001	WO2001090069A1 Novel calcium receptor active molecules and method for preparing same
11/29/2001	WO2001090068A2 Mannich base prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use a modulators of protein kinases
11/29/2001	WO2001090063A2 Prodrug of an ice inhibitor
11/29/2001	WO2001089569A1 Combinations of enzyme inhibitor-containing preparations and the use thereof
11/29/2001	WO2001089548A2 Pharmaceutical use of fibulin-1
11/29/2001	WO2001089514A2 Pharmaceutical composition comprising a free-radical scavenging sedative agent and a metal ion chelating agent
11/29/2001	WO2001089478A1 Carbohydrate medical solution and sulphite stabilisator in a multiple compartment container and use thereof
11/29/2001	WO2001089454A2 Proteus mirabilis-based vaccine
11/29/2001	WO2001070695A8 Pyridine derivatives as inhibitors of p38
11/29/2001	WO2001049305A3 Process for obtaining thylakoids from plants, pure thylakoids and use thereof
11/29/2001	WO2001038566A3 Screening method for candidate drugs
11/29/2001	WO2000055159A3 Substituted aza-oxindole derivatives
11/29/2001	WO2000039114A3 Substituted oximes and hydrazones as neurokinin antagonists
11/29/2001	US20010047079 Caused by rhabdomyolysis or myoglobinuria
11/29/2001	US20010047008 Allosteric adenosine receptor modulators
11/29/2001	US20010046993 5-memberd heteroaryl substituted 1,4-dihydropyridine compounds as bradykinin antagonists
11/29/2001	US20010046959 Method of treating cancer with anti-neurotrophin agents
11/29/2001	DE10025728A1 Neue Carbamate und Harnstoffe, ihre Herstellung und Verwendung als Endothelin-Rezeptorantagonisten New carbamates and ureas, their preparation and use as endothelin receptor antagonists
11/29/2001	DE10024451A1 Pharmazeutische Darreichungsform für Peptide, Verfahren zu deren Herstellung und Verwendung Pharmaceutical form of administration for peptides, process for their preparation and use
11/29/2001	CA2429199A1 Drug metabolizing enzymes
11/29/2001	CA2410520A1 Mutated eukariotic translation initiation factor 2 alpha kinase 3, eif2ak3, in patients with neonatal insulin-dependent diabetes and multiple epiphyseal dysplasia (wolcott-rallison syndrome)
11/29/2001	CA2410096A1 Card domain containing polypeptides, encoding nucleic acids, and methods of use
11/29/2001	CA2409430A1 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as protein kinase modulators
11/29/2001	CA2409367A1 1-(pyrrolidin-1-ylmethyl)-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives
11/29/2001	CA2408709A1 Mannich base prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use a modulators of protein kinases
11/29/2001	CA2408141A1 Neurotransmitter transporters
11/29/2001	CA2408140A1 G-protein coupled receptors
11/29/2001	CA2408033A1 Pharmaceutical composition comprising a free-radical scavenging sedative agent and a metal ion chelating agent
11/29/2001	CA2407780A1 Fluoroalkoxy-substituted benzamide dichloropyridinyl n-oxide pde4 inhibitor
11/29/2001	CA2403574A1 Carbohydrate medical solution and sulphite stabilisator in a multiple compartment container and use thereof
11/29/2001	CA2380935A1 Caspase inhibitors and uses thereof
11/28/2001	EP1158002A1 Human G-protein coupled receptor
11/28/2001	EP1157992A1 Dihydro-2,3-Benzodiazepine derivatives
11/28/2001	EP1157104A2 Pyk2 binding proteins
11/28/2001	EP1157021A1 Sulfamato hydroxamic acid metalloprotease inhibitor
11/28/2001	EP0853483A4 Novel peptides
11/28/2001	EP0660716B1 Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
11/28/2001	CN1324403A PRV-1 gene and the use thereof
11/28/2001	CN1324394A Method for extracting lipid from marine and aquatic animal tissues
11/28/2001	CN1324344A N-(2-aryl-propionyl)-sulfonamides and pharmaceutical preparations containing them
11/28/2001	CN1323623A Multipurpose medicine made of bamboo liquid and honey and its prepn.
11/28/2001	CN1323604A Foamed disease-treating ointment
11/28/2001	CN1323593A Anus perfusion drug for treating prostatitis
11/28/2001	CN1323591A Composite medicine for treating prostatitis

1 ... 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 ... 562